REXANNA TATLOCK: Open Payments
NPI 1851877328 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 9 payments from 7 companies in 2025. Trend: 2023 $155 · 2024 $306 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $63 |
| Amgen Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
| Boston Scientific Corporation | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: COBALT DR MRI SURESCAN, PERCLOSE PROSTYLE, WATCHMAN FLX, Attruby, AZURE XT DR MRI SURESCAN, FARXIGA, COREVALVE EVOLUT R, LifeVest.
Industry payments across IN — which companies pay providers there.
